Apparatus for releasing tablets from a blister pack
    82.
    发明授权
    Apparatus for releasing tablets from a blister pack 失效
    用于从泡罩包装释放片剂的装置

    公开(公告)号:US07431160B2

    公开(公告)日:2008-10-07

    申请号:US10531139

    申请日:2003-10-13

    IPC分类号: B65D85/42 B65D83/04 B65D1/09

    CPC分类号: B65D83/0463 A61J1/035

    摘要: Apparatus for releasing tablets from a blister pack has a tray, a lid pivotally mounted on the tray and a peg slidably mounted on the lid. A base is formed integrally with side walls of the tray, a raised floor for receiving the blister pack extends across the tray and is spaced from the base to define a cavity. A partition wall extends between the side walls at one end of the floor and includes a raised portion which defines a gap between the wall and floor which enables the cavity to communicate with an end receptacle defined by the floor and a part circular end wall. The peg is movable into registry with any selected blister and the floor is provided with apertures to allow released tablets to pass through the floor into the cavity and from the cavity into the end receptacle.

    摘要翻译: 用于从泡罩包装释放片剂的装置具有托盘,可枢转地安装在托盘上的盖和可滑动地安装在盖上的钉。 基座与托盘的侧壁一体地形成,用于接收泡罩包装的高架地板延伸穿过托盘,并且与基座间隔开以限定空腔。 分隔壁在地板的一端处在侧壁之间延伸并且包括限定壁和地板之间的间隙的凸起部分,其使得空腔能够与由地板和部分圆形端壁限定的端部接口连通。 钉可移动到与任何选定的泡罩对准,并且地板设置有孔,以允许释放的片剂通过地板进入空腔并且从空腔进入端部容器。

    Dosage Form With Improved Release Of Cefuroximaxetil
    83.
    发明申请
    Dosage Form With Improved Release Of Cefuroximaxetil 失效
    剂型改善头孢曲松的释放

    公开(公告)号:US20080187594A1

    公开(公告)日:2008-08-07

    申请号:US11912627

    申请日:2006-04-25

    摘要: The invention relates to a pharmaceutical composition comprising cefuroximaxetil and at least one carrageenan selected from the group consisting of κ-carrageenan, λ-carrageenan and τ-carrageenan. The invention furthermore relates to pellets, to a multiparticulate, pharmaceutical dosage form and to a novel crystalline modification of cefuroximaxetil.

    摘要翻译: 本发明涉及包含头孢曲松和至少一种选自卡拉胶角叉菜胶,λ-角叉菜胶和tau-角叉菜胶的角叉菜胶的药物组合物。 本发明还涉及丸剂,多颗粒剂型药物剂型和头孢曲松新颖结晶改性剂。

    Compositions and methods for the treatment of urinary incontinence
    85.
    发明授权
    Compositions and methods for the treatment of urinary incontinence 失效
    用于治疗尿失禁的组合物和方法

    公开(公告)号:US07361690B2

    公开(公告)日:2008-04-22

    申请号:US10978565

    申请日:2004-11-02

    IPC分类号: A61K31/135

    CPC分类号: A61K31/13

    摘要: A method for treating increased uninary urgency or urinary incontinence, comprising administering an effective amount of a compound corresponding to formula I It has been surprisingly discovered that the methods of the present invention are effective for treating increased urinary urgency or urinary incontinence. Also disclosed are methods of treatment using related pharmaceutical compositions.

    摘要翻译: 一种治疗增加的一般尿急或尿失禁的方法,包括给予有效量的对应于式I的化合物已经令人惊奇地发现,本发明的方法对于治疗增加的尿急或尿失禁是有效的。 还公开了使用相关药物组合物的治疗方法。

    PHARMACEUTICAL COMBINATION
    88.
    发明申请
    PHARMACEUTICAL COMBINATION 审中-公开
    药物组合

    公开(公告)号:US20070254960A1

    公开(公告)日:2007-11-01

    申请号:US11741420

    申请日:2007-04-27

    IPC分类号: A61K31/137

    摘要: A combination comprising as components (a) the compound 3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol, and (b) Paracetamol or a derivative thereof, a pharmaceutical formulation and a dosage form comprising said combination as well as a method of treating pain, e.g. chronic or acute pain, characterized in that components (a) and (b) are administered simultaneously or sequentially to a mammal, wherein component (a) may be administered before or after component (b) and wherein components (a) or (b) are administered to the mammal either via the same or a different pathway of administration.

    摘要翻译: 包含作为组分(a)化合物3-(3-二甲基氨基-1-乙基-2-甲基 - 丙基) - 苯酚和(b)对乙酰氨基酚或其衍生物的组合物的组合,药物制剂和包含所述组合 以及治疗疼痛的方法,例如 慢性或急性疼痛,其特征在于组分(a)和(b)同时或依次施用于哺乳动物,其中组分(a)可以在组分(b)之前或之后施用,其中组分(a)或(b) 通过相同或不同的施用途径向哺乳动物施用。